
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 137.230 | 164.320 | 27.090 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.106 | 15.765 |
Price to Book | 3.476 | 2.219 |
Price to Sales | 1.262 | 1.614 |
Price to Cash Flow | 14.244 | 10.612 |
Dividend Yield | 1.050 | 2.529 |
5 Years Earnings Growth | 10.401 | 11.589 |
Number of long holdings: 145
Number of short holdings: 90
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 6.65 | 10,368.0 | -1.20% | |
Sanofi | FR0000120578 | 6.13 | 83.35 | +0.79% | |
Novo Nordisk B | DK0062498333 | 5.79 | 432.5 | -0.14% | |
UnitedHealth | US91324P1021 | 5.74 | 291.71 | -2.95% | |
Eli Lilly | US5324571083 | 4.88 | 771.75 | -3.45% | |
Vertex | US92532F1003 | 4.58 | 464.20 | -1.73% | |
McKesson | US58155Q1031 | 4.50 | 710.82 | -0.66% | |
Boston Scientific | US1011371077 | 4.28 | 103.48 | -0.81% | |
Glaukos Corp | US3773221029 | 3.76 | 98.26 | -5.69% | |
Gilead | US3755581036 | 3.70 | 109.06 | -2.70% |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review